News

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
Artificial intelligence is beginning to reshape how drug companies interact with the Food and Drug Administration, though most changes so far have been limited.
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.
Everyone says they’re using AI in 2025, but how does the FDA actually plan to take advantage of the technology to improve efficiency at the agency? Well, just last week, the FDA launched Elsa ...
Regardless, experts aren't impressed with the AI agenda ... oversight work to an untested chatbot. Elsa's rollout comes after over 2,000 of the FDA's 10,000 workers have been sent packing ...